What is the latest news on SLBT?

In the last 30 days Quantisnow tracked 3 wire items for SLBT: 2 insider trades and 1 SEC filing. The most recent was published on November 6, 2026.

Where does SLBT stock trade?

SL Science Holding Limited (SLBT) is listed on NASDAQ.

What sector and industry is SLBT in?

SL Science Holding Limited operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.

What companies are similar to SLBT?

Notable peers in the same industry include AMGN (Amgen Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), RVMD (Revolution Medicines Inc.), GILD (Gilead Sciences Inc.). Compare SLBT side-by-side with any of them on Quantisnow.

How can I track SLBT on Quantisnow?

Quantisnow aggregates SL Science Holding Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SLBT to receive live email and push alerts on every new disclosure.

SLBT

NASDAQ

SL Science Holding Limited

SectorHealth Care IndustryBiotechnology: Biological Products (No Diagnostic Substances)

Follow + get alerts

Website

SL Science Holding Limited (SLBT) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for SLBT, including 2 insider trades and 1 SEC filing. The most recent was published Nov 6, 2026.

SL Science Holding Limited is a biomedical company specializing in developing innovative cellular and gene therapies.Established with a commitment to advancing regenerative medicine and cancer treatment, the Company hopes to utilize immune cell technologies to target cancer, thus potentially offering expansive medical applications for its products.With proprietary technologies such as Gamma Delta T cells targeting solid tumor indications including pancreatic and brain cancers, SL Science aims to create cellular therapies that we believe have the potential to revolutionize the cell therapy and immuno-oncology sector within the broader biopharmaceutical industry.

News · 26 weeks3+100%

2026-05-172026-11-08

Mix390d

Insider2(67%)
SEC Filings1(33%)

Activity · 52 weeks32 active days

Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

3 items

SLBT FAQ

6 questions

What does SL Science Holding Limited do?
SL Science Holding Limited is a biomedical company specializing in developing innovative cellular and gene therapies.Established with a commitment to advancing regenerative medicine and cancer treatment, the Company hopes to utilize immune cell technologies to target cancer, thus potentially offering expansive medical applications for its products.With proprietary technologies such as Gamma Delta T cells targeting solid tumor indications including pancreatic and brain cancers, SL Science aims to create cellular therapies that we believe have the potential to revolutionize the cell therapy and...
What is the latest news on SLBT?
In the last 30 days Quantisnow tracked 3 wire items for SLBT: 2 insider trades and 1 SEC filing. The most recent was published on November 6, 2026.
Where does SLBT stock trade?
SL Science Holding Limited (SLBT) is listed on NASDAQ.
What sector and industry is SLBT in?
SL Science Holding Limited operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
What companies are similar to SLBT?
Notable peers in the same industry include AMGN (Amgen Inc.), ARGX (argenx SE), MRNA (Moderna Inc.), RVMD (Revolution Medicines Inc.), GILD (Gilead Sciences Inc.). Compare SLBT side-by-side with any of them on Quantisnow.
How can I track SLBT on Quantisnow?
Quantisnow aggregates SL Science Holding Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SLBT to receive live email and push alerts on every new disclosure.